Corcept Therapeutics (CORT) News Today → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free CORT Stock Alerts $24.52 -0.54 (-2.15%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ2 2024 EPS Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT) Increased by HC Wainwrightamericanbankingnews.com - May 4 at 1:58 AMCorcept Therapeutics (NASDAQ:CORT) Shares Down 4.5% marketbeat.com - May 3 at 9:54 PMCorcept Therapeutics First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 3 at 8:23 PMQ2 2024 EPS Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT) Lifted by Analystmarketbeat.com - May 3 at 8:00 AMCorcept Therapeutics (NASDAQ:CORT) Downgraded by StockNews.comamericanbankingnews.com - May 3 at 2:22 AMCorcept Therapeutics (NASDAQ:CORT) Shares Gap Up Following Strong Earningsamericanbankingnews.com - May 3 at 1:46 AMCorcept Therapeutics (NASDAQ:CORT) Price Target Raised to $40.00marketbeat.com - May 2 at 2:38 PMCorcept Therapeutics (NASDAQ:CORT) Issues Earnings Resultsmarketbeat.com - May 2 at 12:54 PMCorcept Therapeutics (NASDAQ:CORT) Shares Gap Up on Strong Earningsmarketbeat.com - May 2 at 12:45 PMQ1 2024 Corcept Therapeutics Inc Earnings Call Transcriptgurufocus.com - May 2 at 1:01 AMCORT Stock Earnings: Corcept Therapeutics Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 1 at 10:02 PMCorcept: Q1 Earnings Snapshotsfgate.com - May 1 at 7:47 PMCorcept Therapeutics Inc (CORT) Outperforms Analyst Estimates in Q1 2024finance.yahoo.com - May 1 at 7:47 PMCorcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Updateglobenewswire.com - May 1 at 4:05 PMJackson Creek Investment Advisors LLC Invests $1.11 Million in Corcept Therapeutics Incorporated (NASDAQ:CORT)marketbeat.com - April 30 at 5:34 PMCorcept Completes Enrollment in Phase 4 CATALYST Trialfinance.yahoo.com - April 29 at 10:10 AMCorcept Therapeutics (CORT) Scheduled to Post Earnings on Wednesdaymarketbeat.com - April 25 at 11:47 AMCorcept Therapeutics (NASDAQ:CORT) Raised to "Strong-Buy" at StockNews.comamericanbankingnews.com - April 25 at 2:20 AMCorcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.3%marketbeat.com - April 24 at 4:21 PMCorcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Callglobenewswire.com - April 24 at 4:05 PMCorcept Therapeutics (NASDAQ:CORT) Receives Buy Rating from HC Wainwrightamericanbankingnews.com - April 24 at 4:42 AMPromising Clinical Outcomes and Market Potential: Buy Rating for Corcept’s Relacorilantmarkets.businessinsider.com - April 23 at 7:28 PMCorcept Therapeutics (NASDAQ:CORT) Trading Up 7.5%marketbeat.com - April 23 at 3:43 PMCorcept Therapeutics (NASDAQ:CORT) Given Buy Rating at HC Wainwrightmarketbeat.com - April 23 at 1:49 PMMid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quartermsn.com - April 22 at 3:34 PMCorcept falls after phase 3 results on Cushing's candidate doesn't include some datamsn.com - April 22 at 3:34 PMCorcept Therapeutics (NASDAQ:CORT) Sets New 52-Week Low at $20.84marketbeat.com - April 22 at 11:59 AMCorcept Therapeutics Sees Unusually Large Options Volume (NASDAQ:CORT)marketbeat.com - April 22 at 11:38 AMCorcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndromefinance.yahoo.com - April 22 at 10:33 AM45,200 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Louisiana State Employees Retirement Systemmarketbeat.com - April 21 at 5:08 AMCerity Partners LLC Has $2.41 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)marketbeat.com - April 19 at 5:13 AMZacks Research Weighs in on Corcept Therapeutics Incorporated's Q3 2025 Earnings (NASDAQ:CORT)marketbeat.com - April 18 at 6:31 AMCorcept Therapeutics (NASDAQ:CORT) Cut to Buy at StockNews.commarketbeat.com - April 17 at 11:13 PMShort Interest in Corcept Therapeutics Incorporated (NASDAQ:CORT) Increases By 5.5%marketbeat.com - April 16 at 6:52 PMMutual of America Capital Management LLC Purchases 36,255 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)marketbeat.com - April 16 at 5:44 AMCorcept Therapeutics Incorporated (CORT)finance.yahoo.com - April 15 at 11:44 PMCorcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)finance.yahoo.com - April 15 at 8:43 AM3 Promising Biotech Stocks Driving Weekly Gainsstocknews.com - April 12 at 1:00 PMUpcoming Deadline to Share in Corcept Therapeutics Incorporated (CORT) Class Action Settlementmsn.com - April 12 at 10:24 AMQ2 2025 EPS Estimates for Corcept Therapeutics Incorporated Raised by Zacks Research (NASDAQ:CORT)marketbeat.com - April 9 at 6:09 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $141,518.00 in Stockinsidertrades.com - April 9 at 4:32 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 5,443 Sharesmarketbeat.com - April 8 at 6:41 PMCorcept Therapeutics (NASDAQ:CORT) Trading Down 3.8%marketbeat.com - April 8 at 3:45 PMCorcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancerfinance.yahoo.com - April 8 at 11:01 AMCorcept Therapeutics director sells shares worth over $55kinvesting.com - April 5 at 4:37 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $13,005.00 in Stockinsidertrades.com - April 4 at 7:09 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 500 Sharesmarketbeat.com - April 3 at 9:46 PMCorcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndromefinance.yahoo.com - April 1 at 10:31 AMCorcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing's Syndromeglobenewswire.com - April 1 at 8:00 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells 25,953 Sharesinsidertrades.com - March 30 at 7:30 AM Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. CORT Media Mentions By Week CORT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼0.820.42▲Average Medical News Sentiment CORT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼225▲CORT Articles Average Week Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Supernus Pharmaceuticals News Today Taro Pharmaceutical Industries News Today Axsome Therapeutics News Today Pacira BioSciences News Today Xencor News Today OPKO Health News Today Perrigo News Today ADC Therapeutics News Today Atea Pharmaceuticals News Today Jazz Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
